Tag: ALCOA+ violations

Common Audit Trail Findings in FDA Inspections

August 6, 2025

Common Audit Trail Findings in FDA Inspections Common Audit Trail Findings in FDA Inspections Introduction: Audit Trails and Regulatory Scrutiny Audit trails are one of the most scrutinized components during FDA inspections of clinical trial systems. Whether it’s an Electronic Data Capture (EDC) platform, eTMF system, or laboratory database, regulators expect complete, accurate, and immutable…

Audit Trails, Data Integrity and ALCOA+ Principles

Common Violations of ALCOA+ Principles and How to Prevent Them

July 31, 2025

digi

Common Violations of ALCOA+ Principles and How to Prevent Them Common Violations of ALCOA+ Principles and How to Prevent Them Understanding ALCOA+ and Its Role in Data Integrity The ALCOA+ framework—Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available—is foundational to GxP compliance across clinical research. Whether data is collected via paper, eSource, or…

Complete, Consistent, Enduring, and Available (ALCOA+), Data Integrity and ALCOA+ Principles

ALCOA Examples from Real Clinical Audits

July 27, 2025

digi

ALCOA Examples from Real Clinical Audits Real-World ALCOA Examples from Clinical Audits and Inspections Why ALCOA Compliance Is Closely Scrutinized During Audits ALCOA principles—Attributable, Legible, Contemporaneous, Original, Accurate—are not just theoretical standards. They are active audit checkpoints during GCP inspections by agencies like the FDA, EMA, and local regulatory authorities. Noncompliance with ALCOA is one…

Attributable, Legible, Contemporaneous, Original, Accurate (ALCOA), Data Integrity and ALCOA+ Principles